Carson Chow, Ph.D., Advisory board member, consultant and co-founder, is an expert in the field of complex systems mathematics and one of the inventors of the Immunetrics technology. Carson is associate professor of mathematics at the University of Pittsburgh, which he joined in 1998. He received his Ph.D. from the Massachusetts Institute of Technology. Carson's research focuses on applied mathematics, with an emphasis on computational biology. In 1999, he was awarded a Sloan Research Fellowship by the Alfred P. Sloan Foundation.
Billy W. Day, Ph.D., Chief Science Consultant, is Associate Professor of Pharmaceutical Sciences, Chemistry and Environmental & Occupational Health at the University of Pittsburgh, as well as founding Director of its Proteomics Facility. He also holds appointments in the Clinical Pharmacology, Molecular Biophysics, Computational Biology & Bioinformatics, Pharmacogenetics, Molecular Pharmacology, Molecular Toxicology, and Computational Toxicology programs at the University of Pittsburgh, and is a member of the University of Pittsburgh Cancer Institute. Billy obtained a double B.S. in Chemistry and Biology from Oklahoma City University and received his Ph.D. in Medicinal Chemistry from the University of Oklahoma. He completed a postdoctoral fellowship at MIT in Chemistry and Toxicology before joining the faculty at the University of Pittsburgh in 1991. Billy serves as consultant to a number of companies including Aventis and Camitro. He is an active member of the American Chemical Society Medicinal Chemistry and Chemical Toxicology sections, including membership on the Editorial Advisory Board for the journal Chemical Research in Toxicology. He is also active in the American Association for Cancer Research Experimental Therapeutics and Molecular Epidemiology sections, including service on the Chemistry in Cancer Research Task Force. Billy has published more than 70 research papers and has given over 120 presentations worldwide. He has also filed a number of patents and has been active in technology development and transfer in the Pittsburgh region. His research has focused on computational drug design, chemical synthesis, pharmacological high-throughput and cell biological high information content screening, and quantitative and qualitative analysis of complex biological mixtures, largely by mass spectrometry.
Steven H. Kleinstein, Ph.D., Advisory board member (www.cs.princeton.edu/~stevenk) is an expert in the field of computational
immunology with over 12 years of experience in computational biology. Steve's research focuses on the development and application of computational methods that leverage mathematical/statistical models and numerical simulations in order to improve understanding of experimental and clinical data. The immune response has been a particular focus of his work. Steve has been associated with several early-stage companies including WorldView Software, Cambridge Technology Group / Object Power, and Physiome Sciences, Inc. (now Predix Pharmaceuticals). At Physiome Sciences, he developed in silico models of disease for large pharmaceutical companies. Steve is currently an Assistant Professor of Pathology at Yale University School of Medicine. He was previously a member of the research staff at Princeton University where he ran the Program in Integrative Information, Computer and Application Sciences (PICASso). He received his Ph.D. in Computer Science from Princeton University in 2002.
Carson Chow, Ph.D., Advisory board member, consultant and co-founder, is an expert in the field of complex systems mathematics and one of the inventors of the Immunetrics technology. Carson is associate professor of mathematics at the University of Pittsburgh, which he joined in 1998. He received his Ph.D. from the Massachusetts Institute of Technology. Carson's research focuses on applied mathematics, with an emphasis on computational biology. In 1999, he was awarded a Sloan Research Fellowship by the Alfred P. Sloan Foundation.
Billy W. Day, Ph.D., Chief Science Consultant, is Associate Professor of Pharmaceutical Sciences, Chemistry and Environmental & Occupational Health at the University of Pittsburgh, as well as founding Director of its Proteomics Facility. He also holds appointments in the Clinical Pharmacology, Molecular Biophysics, Computational Biology & Bioinformatics, Pharmacogenetics, Molecular Pharmacology, Molecular Toxicology, and Computational Toxicology programs at the University of Pittsburgh, and is a member of the University of Pittsburgh Cancer Institute. Billy obtained a double B.S. in Chemistry and Biology from Oklahoma City University and received his Ph.D. in Medicinal Chemistry from the University of Oklahoma. He completed a postdoctoral fellowship at MIT in Chemistry and Toxicology before joining the faculty at the University of Pittsburgh in 1991. Billy serves as consultant to a number of companies including Aventis and Camitro. He is an active member of the American Chemical Society Medicinal Chemistry and Chemical Toxicology sections, including membership on the Editorial Advisory Board for the journal Chemical Research in Toxicology. He is also active in the American Association for Cancer Research Experimental Therapeutics and Molecular Epidemiology sections, including service on the Chemistry in Cancer Research Task Force. Billy has published more than 70 research papers and has given over 120 presentations worldwide. He has also filed a number of patents and has been active in technology development and transfer in the Pittsburgh region. His research has focused on computational drug design, chemical synthesis, pharmacological high-throughput and cell biological high information content screening, and quantitative and qualitative analysis of complex biological mixtures, largely by mass spectrometry.
Steven H. Kleinstein, Ph.D., Advisory board member (